A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.

van de Schoot, L; Romme, E A P M; van der Sangen, M J; Creemers, G J; van Lijnschoten, G; van Driel, O J Repelaer; Rutten, H J T; Nieuwenhuijzen, G A P

van de Schoot, L; Romme, E A P M; van der Sangen, M J; Creemers, G J; van Lijnschoten, G; van Driel, O J Repelaer; Rutten, H J T; Nieuwenhuijzen, G A P.

Affiliation

van de Schoot L; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands. scho4190@planet.nl

Ann Surg Oncol ; 15(1): 88-95, 2008 Jan.

Article in En | MEDLINE | ID: mdl-17896144

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Esophageal Neoplasms/therapy; Adenocarcinoma/drug therapy; Adenocarcinoma/pathology; Adenocarcinoma/radiotherapy; Adult; Aged; Carboplatin/administration & dosage; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/pathology; Carcinoma, Squamous Cell/radiotherapy; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms/drug therapy; Esophageal Neoplasms/pathology; Esophageal Neoplasms/radiotherapy; Feasibility Studies; Female; Fluorouracil/administration & dosage; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel/administration & dosage; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Netherlands Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google